![]() |
| Electron microscopy image of the nanopipette. Photo Credit: Dr Alexander Kulak |
A nanosurgical tool - about 500 times thinner than a human hair - could give insights into cancer treatment resistance that no other technology has been able to do, according to a new study.
The high-tech double-barrel nanopipette, developed by University of Leeds scientists, and applied to the global medical challenge of cancer, has - for the first time - enabled researchers to see how individual living cancer cells react to treatment and change over time – providing vital understanding that could help doctors develop more effective cancer medication.
The tool has two nanoscopic needles, meaning it can simultaneously inject and extract a sample from the same cell, expanding its potential uses. And the platform’s high level of semi-automation has sped up the process dramatically, enabling scientists to extract data from many more individual cells, with far greater accuracy and efficiency than previously possible, the study shows.
Currently, techniques for studying single cells usually destroy them, meaning a cell can be studied either before treatment, or after.
This device can take a “biopsy” of a living cell repeatedly during exposure to cancer treatment, sampling tiny extracts of its contents without killing it, enabling scientists to observe its reaction over time.
During the study, the multi-disciplinary team, featuring biologists and engineers, tested cancer cells’ resistance to chemotherapy and radiotherapy using glioblastoma (GBM) - the deadliest form of brain tumor - as a test case, because of its ability to adapt to treatment and survive.


.jpg)
.jpg)



.jpg)



.jpg)
.jpg)
.jpg)
.jpg)